Showing results (81-90 of 141) with videos related to

Sort By:
Pageof 15
Metabolism: Clinical and Experimental|September 10, 2015
Mandibular hypoplasia, deafness, progeroid features and lipodystrophy (MDPL) syndrome in the context of inherited lipodystrophiesFrederic Reinier, Magdalena Zoledziewska, David Hanna, et al.
Plos One|August 1, 2012
Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated allelesEleonora Cocco, Alessandra Meloni, Maria Rita Murru, et al.
Experimental Hematology|July 25, 2016
A genome-wide association study by ImmunoChip reveals potential modifiers in myelodysplastic syndromesFabrice Danjou, Claudio Fozza, Magdalena Zoledziewska, et al.
European Journal of Neurology|December 26, 2024
Effect of autoimmune comorbidities on multiple sclerosis course: An observational multicenter studyViviana Nociti, Marina Romozzi, Luca Prosperini, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 1, 2018
Kidney size in relation to ageing, gender, renal function, birthweight and chronic kidney disease risk factors in a general populationDoloretta Piras, Marco Masala, Alessandro Delitala, et al.
Journal of the Neurological Sciences|January 14, 2025
Effectiveness, safety, and impact on multiple sclerosis course of anti-CGRP monoclonal antibodiesViviana Nociti, Marina Romozzi, Pietro Annovazzi, et al.
NPJ Parkinson'S Disease|February 10, 2026
Genetic co-regulation of neopterin and Parkinson's diseaseValeria Orrù, Michele Marongiu, Maristella Steri, et al.
Journal of Neurology|January 3, 2024
Late-onset multiple sclerosis: disability trajectories in relapsing-remitting patients of the Italian MS RegistryLorena Lorefice, Ottavia Elena Ferraro, Giuseppe Fenu, et al.
Immunology|January 21, 2025
TYK2 :p.Pro1104Ala Variant Protects Against Autoimmunity by Modulating Immune Cell LevelsMaristella Steri, Valeria Orrù, Carlo Sidore, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 11, 2023
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTsRocco Capuano, Luca Prosperini, Manuela Altieri, et al.
Pageof 15